Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2022C547 Product name: voclosporine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2022C/547
Type:
Certificate
SPC type:
Medical
Basic patent number:
027670280
Status:
Active
Publication number:
2022C547
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/22/1678
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
15/09/2022
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
14/10/2022
First marketing authorization date:
15/09/2022
Grant date:
19/10/2022
Activation date:
17/10/2022
BE Publication date:
17/10/2022
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
17/10/2027
SPC/SPC Extension Expiration (if granted and all annual fees paid):
17/10/2027
Rejection date:
Withdrawal date:

Applicant

Name:
Aurinia Pharmaceuticals
Legal Form:
Inc.
From:
17/10/2022
Address:
1203-4464 Markham Street, V8Z 7X8, Victoria, British Columbia, Canada (CA)
To:

Agent

Name:
JAEKEN Annemie
Legal Form:
From:
15/10/2022
Address:
Gaston Geenslaan 11, 3001, LEUVEN, Belgium (BE)
To:

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2022/20
Publication date:
21/11/2022
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
SPC
Journal edition number:
2022/20
Publication date:
21/11/2022
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

3

Bulletin heading:
SPC
Journal edition number:
2022/20
Publication date:
21/11/2022
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

Annual fee

Annual fee(s) Due Date:
31/10/2025
Annual fee number:
24
Annual fee amount:
800 Euro
Expected payer:
Last annual fee payment date:
17/09/2024
Last annual fee paid number:
23
Last annual fee paid amount:
750 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
17/10/2022 Publication I1 1 PDF /8/3/4/0/6/0722260438/docs/2022c547_0_i1document_20221017_142237428.pdf
19/10/2022 Publication I2 1 PDF /8/3/4/0/6/0722260438/docs/2022c547_1_i2document_20221019_124519603.pdf
19/10/2022 Certificate 2 PDF /8/3/4/0/6/0722260438/docs/2022c547_2_spc_medcertificate_20221019_124519773.pdf
14/10/2022 General Document Other 2 PDF /8/3/4/0/6/0722260438/docs/2022c547_3_generaldocument_20221015_084655824.pdf
14/10/2022 Abstract Product Characteristics Abstract of the characteristics of the product 32 PDF /8/3/4/0/6/0722260438/docs/2022c547_4_abstractproductcharacteristics_20221015_084656343.pdf
14/10/2022 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /8/3/4/0/6/0722260438/docs/2022c547_5_marketingauthorization_20221015_084656724.pdf
14/10/2022 Power Of Attorney Power of attorney 1 PDF /8/3/4/0/6/0722260438/docs/2022c547_6_powerofattorney_20221015_084657388.pdf
14/10/2022 Application Form 4 PDF /8/3/4/0/6/0722260438/docs/2022c547_7_applicationform_20221015_084657617.pdf
17/10/2022 Outgoing Correspondence 2 PDF /8/3/4/0/6/0722260438/docs/2022c547_8_outgoingcorrespondence_20221019_103246553.pdf
19/10/2022 Outgoing Correspondence 2 PDF /8/3/4/0/6/0722260438/docs/2022c547_9_outgoingcorrespondence_20221024_091510014.pdf